Pet Medication Innovation Watch

Pennitracin MD 50G® and Monteban™ (bacitracin Type A medicated article) and

Pennitracin MD 50G® and Monteban™ (bacitracin Type A medicated article) and / narasin Type A medicated article

Recently FDA-confirmed FDA-confirmed FDA-confirmed

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.

Veterinary professional?

What this means

Owner summary

This is a public veterinary medicine update Roxee is tracking with source-backed evidence and availability labels.

Do not start, stop, or switch medicine without your veterinarian.
Development-stage products are not shown as available unless FDA approval or marketed evidence is public.
Ask your veterinarian about currently approved options for fda-confirmed approval.

Vet view

Technical note

No vet-facing summary has been approved for this innovation record yet.

Regulator: FDA/CVM
Pathway: NADA/ANADA/CNADA
FDA application: Not publicly linked

Regulatory timeline

Public stage evidence

Only supported or current stages are highlighted.

1 Early research signal
2 Company-disclosed development
3 FDA-CVM development path disclosed
4 Protocol concurrence disclosed
5 Pivotal study planned
6 Pivotal study recruiting
7 Pivotal study completed
8 Technical section submitted
9 Technical section complete
10 All major technical sections complete
11 Administrative NADA/CNADA submitted
12 FDA approved
13 Conditionally approved
14 Available / marketed

What changed

Latest public update

Date detected: May 19, 2026
Stage: FDA approved
Reason: MIW source adapter refresh

Owner-safe interpretation

Availability

FDA-confirmed status means Roxee found public approval or market-status evidence. Ask your veterinarian whether this option applies to your pet.

Expected availability: FDA approved, launch unclear

Evidence

Source-backed record

1 item shown

Pennitracin MD 50G® and Monteban™ (bacitracin Type A medicated article) and FDA recent animal drug approval FDA approval / Animal Drugs @ FDA · Primary source 100/100

Source: FDA Recent Animal Drug Approvals
Observed: May 19, 2026
Supports: FDA approved

1) For increased rate of weight gain and improved feed efficiency, and for the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens. 2) For the prevention of mortality caused by necrotic enteritis associated with Clostridium perfri...

View source evidence